Evaluation of the Efficacy and Safety of Intravenous Immunoglobulin (IVIG) in Moderate-to-Severe Hospitalized COVID-19 Patients: A Randomized, Open-Label Parallel-Group Study.

Can J Infect Dis Med Microbiol · 2024 · PMC11132825 · PMID 38808260

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

very close to significanceno p-value reported

The trend was significant for the SoC group and was very close to significance in the IVIG group.

also in 191 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.